Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose in Chronic Heart Failure with Iron Deficiency
NCT01453608Phase 4Completed
- Sponsor
- CSL Vifor
- Start
- Oct 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by CSL Vifor. Started Oct 2011; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01453608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453608.